We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Major Biomedical Research Reagents Supplier Licences Chromatrap ChIP Technology

Product News   Jun 29, 2017 | Original story from Chromatrap

 
Major Biomedical Research Reagents Supplier Licences Chromatrap ChIP Technology
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Biotinylated Heparan Sulfate Antibodies

Product News

AMSBIO has launched two new biotinylated formats of the 10E4 Heparan Sulfate antibody (high and low biotin) along with a starter pack to allow scientists to test both formats at a reduced cost.

READ MORE

Memo Therapeutics AG Antibodies Against SARS-CoV-2 Show Efficacy Against British and South African Variant

Product News

Memo Therapeutics AG has announced that MTX-COVAB, its human-derived antibody against SARS-CoV-2, the virus that causes COVID-19, has shown efficacy against both the original virus as well as the UK variant (B.1.1.7).

READ MORE

Sphere Fluidics Announces Enhanced Cyto-Mine Capability and Performance

Product News

Sphere Fluidics has announced it has enhanced the capability and performance of its Cyto-Mine® System. The simplified design offers improved functionality to help streamline workflows, reduce costs, increase throughput, and enable high-value clones to be captured in a single run.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE